Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian CancerChangxin Wan, Sarah J. Hill, Matthew P. Keany et al.|Cancer Research|2020Cited by 215
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Kornélia Polyák, Hua‐Jun Wu et al.|Molecular Cell|2020Cited by 207
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C. Watt, Shom Goel, Paloma Cejas et al.|Nature Cancer|2020Cited by 110
Cancer–stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapiesMarie-Anne Goyette, Kornélia Polyák, Carolyn R. Bertozzi et al.|Proceedings of the National Academy of Sciences|2024Cited by 28
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Cancer Research|2023Cited by 15